| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/04/2012 | CN102526083A Pharmaceutical composition for preventing or treating hepatitis C |
| 07/04/2012 | CN102526082A Compound glycyrrhizin soluble powder for livestock and preparation method thereof |
| 07/04/2012 | CN102526081A Medicinal composition capable of inhibiting proliferation of tumor cells |
| 07/04/2012 | CN102526080A Medicinal composition and tablet containing salicylic acid methyl ester lactoside and preparation methods thereof |
| 07/04/2012 | CN102526079A 治疗脱髓鞘疾病的鞘氨醇-1-磷酸受体激动剂 Treatment of demyelinating diseases of the sphingosine-1-phosphate receptor agonist, |
| 07/04/2012 | CN102526078A Compound betamethasone suspension injection and preparation method thereof |
| 07/04/2012 | CN102526077A Application of phenylacetyl fluorobenzene salicylamide compound for preparing anti-leukemia drugs |
| 07/04/2012 | CN102526076A Animal application of aspirin derivative |
| 07/04/2012 | CN102526075A Fat-soluble vitamin freeze-dried injection and preparation method thereof |
| 07/04/2012 | CN102526074A Combination of methylxanthine compounds and steroids to treat chronic respiratory diseases |
| 07/04/2012 | CN102526073A Application of mogrol H9 for preparing antitumor drugs |
| 07/04/2012 | CN102526072A Application of Lanosta-7,9(11),24-trien-3-one 15,26-dihydroxy-sterane triterpene in preparation of medicament for preventing and/or treating EV71 infection |
| 07/04/2012 | CN102526071A Application of Ppt for resisting cognition and learning and memorial dysfunctions |
| 07/04/2012 | CN102526070A Compound bifonazole nano-emulsion spray preparation and preparation method thereof |
| 07/04/2012 | CN102526069A External norgesterone acetate contraception preparation and preparation method thereof |
| 07/04/2012 | CN102526068A Medicinal composition for treating female postmenopausal osteoporosis |
| 07/04/2012 | CN102526067A Antimalarial drug taking protein degradation pathway as target |
| 07/04/2012 | CN102526066A Separate type water suspension medicament of fluticasone propionate containing auxiliary materials for treating skin disease |
| 07/04/2012 | CN102526065A Compound injection preparation for treating cardiovascular and cerebrovascular diseases and preparation method thereof |
| 07/04/2012 | CN102526064A Product containing prostaglandin having fluorine atom in its molecule |
| 07/04/2012 | CN102526063A Compound preparation containing losartan potassium and hydrochlorothiazide and preparation method for compound preparation |
| 07/04/2012 | CN102526062A Valsartan and hydrochlorothiazide oral solid preparation with high medicament loading capacity |
| 07/04/2012 | CN102526061A Medicinal composition and preparation method thereof |
| 07/04/2012 | CN102526060A Compound cefixime nano-emulsion antibacterial drug and preparation method thereof |
| 07/04/2012 | CN102526059A Cefprozil medicinal composition |
| 07/04/2012 | CN102526058A Anti-inflammatory analgesic medicinal composition containing lornoxicam and esomeprazole |
| 07/04/2012 | CN102526057A Quinazoline derivative as pgk1 (phosphoglycerate kinase 1) activator |
| 07/04/2012 | CN102526056A Voriconazole ear drop and preparation method and application thereof |
| 07/04/2012 | CN102526055A Application of cyclohexanediamine hypocrelline B in photodynamic anti-tumor medicaments |
| 07/04/2012 | CN102526054A Compound enrofloxacin pellets and preparation method thereof |
| 07/04/2012 | CN102526053A Composition containing gallocatechin epicatechol gallate and vincristine and capable of inhibiting proliferation of tumor cells |
| 07/04/2012 | CN102526052A Application of 2-gylcosyl chinoline compound in preparing acetylcholine esterase resisting medicines |
| 07/04/2012 | CN102526051A Eye ointment for treating fungal keratitis |
| 07/04/2012 | CN102526050A Stable simvastatin compound preparation and preparation method thereof |
| 07/04/2012 | CN102526049A Compound diclofenac sodium slow-release preparation and preparation method thereof |
| 07/04/2012 | CN102526048A Multi-layer coated tablet containing telmisartan and amlodipine |
| 07/04/2012 | CN102526047A Model of monkey with chronic systemic Parkinson's disease and method for sieving medicament for treating chronic systemic Parkinson's disease |
| 07/04/2012 | CN102526046A Antitumor medicinal composition containing epigallocatechin gallate (EGCG) and sorafenib and application thereof |
| 07/04/2012 | CN102526045A Methods of increasing endogenous erythropoietin EPO |
| 07/04/2012 | CN102526044A Methods of increasing endogenous erythropoietin EPO |
| 07/04/2012 | CN102526043A Transdermal granisetron |
| 07/04/2012 | CN102526042A Stable liquid medicinal composition |
| 07/04/2012 | CN102526041A Application of picrasma quassioides alkaloid serving as STAT3 (Signal Transducer and Activator of Transcription 3) signal specificity inhibitor |
| 07/04/2012 | CN102526040A Method for preparing composition of mezlocillin sodium and sulbactam sodium for injection in ratio of 4: 1 |
| 07/04/2012 | CN102526039A Oil-in-water-type compound nitazoxanid nanoemulsion and preparation method thereof |
| 07/04/2012 | CN102526038A Temozolomide brain-targeting pharmaceutical composition and application thereof |
| 07/04/2012 | CN102526037A Telmisartan medicinal composition, telmisartan medicinal composition tablets and preparation method for telmisartan medicinal composition tablets |
| 07/04/2012 | CN102526036A Butylphthalide- and edaravone-containing compound injection and preparation method thereof |
| 07/04/2012 | CN102526035A Pharmaceutical composition for treating cerebrovascular diseases |
| 07/04/2012 | CN102526034A Establishment of fulminant liver function failure model of rhesus |
| 07/04/2012 | CN102526033A Composition prepared from epigallocatechin gallate and mitomycin C and used for suppressing tumor cell proliferation |
| 07/04/2012 | CN102526032A Formula of liposome preparation containing compound amino acid and preparation method thereof |
| 07/04/2012 | CN102526031A Sumatriptan pharmaceutical composition used in nasal cavity and preparation method thereof |
| 07/04/2012 | CN102526030A Application of 3,3'-diindolylmethane in treating inflammatory bowel disease |
| 07/04/2012 | CN102526029A Pharmaceutical combination comprising atorvastatin derivatives |
| 07/04/2012 | CN102526028A Application of esculetin |
| 07/04/2012 | CN102526027A Application of furocoumarin compounds for preparing vasodilators |
| 07/04/2012 | CN102526026A Use of 15-benzylidene-14-deoxy-11, 12-dehydro-andrographolide derivative for preparation of liver protection medicaments |
| 07/04/2012 | CN102526025A Method for preparing ginkgo leaf extractive containing a plurality of appointed active ingredients |
| 07/04/2012 | CN102526024A Anticancer pharmaceutical composition |
| 07/04/2012 | CN102526023A Application of EGCG (epigallocatechin gallate) in preparing medicine for treating type-II diabetes |
| 07/04/2012 | CN102526022A Application of epigallocatechin-3-gallate in preparation of antitumor drug |
| 07/04/2012 | CN102526021A Medicinal combination for cranial nerve protection |
| 07/04/2012 | CN102526020A Application of oridonin in preparing activator of tumor-suppressor protein FBW7 |
| 07/04/2012 | CN102526019A Use of usnic acid and derivatives of usnic acid for preparation of medicaments for treating skin diseases caused by malassezia |
| 07/04/2012 | CN102526018A Application of carbamic acid alkannin ester to preparation of pyruvate kinase inhibitor |
| 07/04/2012 | CN102526017A Gabexate mesilate pharmaceutical composition and preparation method of freeze-dried powder injection thereof |
| 07/04/2012 | CN102526016A Application of 5,8-dyhydroxyl-2-(1-acetyl-4-methyl-3-pentenyl)-1,4-naphthoquinone diketone to preparation of medicines for resisting diabetes |
| 07/04/2012 | CN102526015A Application of 3-(3,4-dihydroxycinnamoyl) quinic acid to preparation of medicines or food for preventing and treating ovulation disorder |
| 07/04/2012 | CN102526014A Improved osletamirvir phosphate medicinal composition |
| 07/04/2012 | CN102526013A Medicament composition and application thereof |
| 07/04/2012 | CN102526012A Application of retinoic acid and derivatives thereof to preparation of medicines for treating hepatic fibrosis |
| 07/04/2012 | CN102526011A Application of retinoic acid in preparing medicines for curing breast cancer |
| 07/04/2012 | CN102526010A Compound undecylenic nanoemulsion and preparation method thereof |
| 07/04/2012 | CN102526009A Zinc calcium gluconate oral solution |
| 07/04/2012 | CN102526008A Beriberi ointment |
| 07/04/2012 | CN102526007A Florfenicol taste masking preparation and preparation method for same |
| 07/04/2012 | CN102526006A Use of amides of mono and dicarboxylic acids in treatment of renal diseases |
| 07/04/2012 | CN102526005A Application of deferoxamine mesylate in preparing medicaments for treating postmenopausal osteoporosis |
| 07/04/2012 | CN102526004A New use of tetrahydrocurcumin |
| 07/04/2012 | CN102526003A New application of tetrahydrocurcumin |
| 07/04/2012 | CN102526001A Indomethacin salt transdermal patch and preparation method thereof |
| 07/04/2012 | CN102526000A Dexibuprofen slow-release capsule and production method thereof |
| 07/04/2012 | CN102525999A Ketotifen fumarate sustained-release capsules and preparation method thereof |
| 07/04/2012 | CN102525998A Preparation process of glutamine enteric microcapsules |
| 07/04/2012 | CN102525997A Moisture-proof coating citicoline sodium capsule and preparation method thereof |
| 07/04/2012 | CN102525996A Capsules containing fludarabine phosphate and preparation method for capsules |
| 07/04/2012 | CN102525993A Delayed release tablet with defined core geometry |
| 07/04/2012 | CN102525992A L-alpha-glycerophosphoryl choline film-coated tablet and preparation method thereof |
| 07/04/2012 | CN102525991A Compound preparation containing pioglitazone hydrochloride and metformin hydrochloride and method for preparing compound preparation containing pioglitazone hydrochloride and metformin hydrochloride |
| 07/04/2012 | CN102525990A Ilaprazole enteric-coated tablets and preparation method thereof |
| 07/04/2012 | CN102525989A Loxoprofen sodium matrix sustained-release tablet |
| 07/04/2012 | CN102525988A Quetiapine fumarate sustained-release tablets |
| 07/04/2012 | CN102525987A Diclofenac sodium slow-release tablet and preparation method thereof |
| 07/04/2012 | CN102525985A Cefaclor sustained-release tablet and preparation method thereof |
| 07/04/2012 | CN102525984A Cinildipine controlled release preparation and preparation method thereof |
| 07/04/2012 | CN102525983A Guanfacine sustained-release tablet and preparation method thereof |
| 07/04/2012 | CN102525982A Stable moxifloxacin hydrochloride medicinal composition |
| 07/04/2012 | CN102525981A Propranolol hydrochloride tablets and preparation method thereof |
| 07/04/2012 | CN102525980A Children cetirizine hydrochloride composition |